[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2022/117487,2022,A1Locationinpatent:Page/Pagecolumn41-42
1035235-32-5
957034-40-1
720692-77-3
1114808-89-7 | 4-Bromo-2-ethylbenzaldehyde | AA0094DU | MFCD09835094
1033330-27-6 | 7-Bromoisoquinoline-1,3(2h,4h)-dione | AA0094PJ | MFCD12756049
1201644-42-9 | N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinamide | AA009548 | MFCD11878276
104040-75-7 | 3-(Trifluoromethyl)pyridine-2-sulfonyl chloride | AA0095JX | MFCD16093662
1187451-28-0 | (4-(Thiazol-2-yl)phenyl)methanamine hydrochloride | AA0095TP | MFCD14525839
1005264-47-0 | MX-69 | AA0096BP | MFCD24858136
1124381-43-6 | Msc 2032964a | AA0096PA | MFCD30182335
1157401-82-5 | 3-cyclohexyl-1-methyl-1H-pyrazole-4-carbaldehyde | AA00970L | MFCD12065559
1185298-58-1 | 3-(2-Allylphenoxy)pyrrolidine hydrochloride | AA0097TY | MFCD11100506
1056456-24-6 | 2-Methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole | AA009946 | MFCD18384931